Accelerated or malignant hypertension is fairly common in black patients. It has an interesting and almost characteristic clinical presentation that nowadays is rarely seen in whites. It occurs mostly in inner city blacks with little or no previous medical care and a tendency to omit taking medicines or miss clinic appointments. A long history of chronic "benign" hypertension is often present, likely to be referred to by the patient as "high blood". Most malignant hypertensives whom we see are under fifty years of age. And whereas the disease was usually fatal thirty years ago, almost all of our patients now survive the initial episode of malignant hypertension. Their ultimate prognosis depends on long term blood pressure control, pre-existing arteriosclerosis, and the presence or absence of significant renal failure.
Although prompt treatment on admission is mandatory, overzealous treatment should be avoided. Very rapid reduction of blood pressure to normotensive or even mildly hypertensive leve!s may cause disastrous ischemic events in these patients (1) (2) (3) (4) . The initial choice of antihypertensive agent is less important than the judicial and experienced use of any of the commonly prescribed drugs. Even more important is close clinical observation once treatment is begun. Fanciful monitors and intra-arterial lines cannot substitute for experienced physicians and nurses.
Although intravenous nitroprusside is widely used in intensive care units for the initial control of hypertensive crisis, good results may be obtained with oral nifedipine (5) or intravenous hydralazine in repeated 10-20 mg doses (6) . The use of these or other agents would also obviate the need for admission to a "high tech" stressful intensive care unit, save the time wasted in getting the patient admitted, and avoid invasive arterial puncture. Furthermore, nitroprusside is not entirely without side effects; it may redistribute blood flow away from ischemic myocardium (7) , raise intracranial pressure, and cause cyanide toxicity.
When the clinical situation is less urgent, which is usually the case, minoxidil can be used with good results (8) (9) (10) (11) (12) . In fact, it usually succeeds in the long term control of resistant hypertension in blacks when other agents fail, but its use in women is limited because it often causes hirsutism.
We discourage the indiscriminate use of diuretics in the initial treatment of accelerated hypertension, although such agents are often given in the emergency room. These patients are often "volume depleted" and the automatic use of diuretics may aggravate renal failure or cause other adverse effects (13) .
Whatever the initial treatment, oral medication for long term therapy should be started soon. We have found blacks with severe hypertension to respond best to diuretics, vasodilators, central alpha adrenergic agonists, and to a lesser extent beta blockers. These agents seem more effective in this population than the highly touted and more expensive ACE inhibitors and calcium channel blockers, especially when these are given without diuretics.
Some patients with accelerated hypertension present with acute renal failure or develop it shortly after admission (9, 14) . With the advent of more effective drugs and dialysis, renal function has improved in an increasing number of these (9, (14) (15) (16) (17) . We have seen seventeen such patients since 1972 (9, 15) , and described the longer term prognosis in ten (9) .
These ten patients (eight men) were black and all had a previous history of hypertension. Cardiomegaly was mild, fundal exudates were present in seven, hemorrhages in five, and papilledema in five. The kidney size was mostly normal on ultrasound examination. Eight were treated with minoidil, and all received hemodialysis (9) .
Renal function recovered to a variable extent in all ten patients and dialysis was stopped after a period ranging from two weeks to two years (6 months ± SO 2). While renal recovery was sustained in half the pa-tients, the other half showed subsequent deterioration of renal function, resuming dialysis after 6-38 months (16±SD 6).
The patients with the sustained recovery had significantly lower serum creatinine values on admission (9 mg/dl ± SD 1.2) and upon recovery from renal failure (1.9± 0.3) than the ones who went back on dialysis (13.6±1.7 and 5.7±1.7 respectively). They also tended to develop renal shutdown faster and recover earlier, to be more oliguric, and to have less proteinuria, and two had a microangiopathic hemolytic anemia with schistocytes in the peripheral blood smear. On the other hand, the patients who resumed dialysis treatment were less compliant with the antihypertensive treatment.
Hence it seems that the patients who do not display marked cardiomegaly or renal shrinkage may have a chance of recovery of renal function, more so if their early course shows "acute" elements, e.g. a rapid renal shutdown as seen in acute tubular necrosis, or the presence of peripheral schistocytes. It is important to bear this in mind to avoid early and possibly unnecessary renal transplantation.
A. BAKIR and G. DUNEA
